clinical trial · NCT02985736
Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray
Psoriasis Treatment Center of Central New Jersey·phase4·completed·n = 20
PsoriasisTopicort Topical Spray
brief summary
A single center, study of 20 subjects to assess 4 weeks of therapy with Topicort® twice daily BID and 12 weeks twice daily on 2 consecutive days to patients with scalp psoriasis
started
Sep 1, 2016
primary completion
Jan 27, 2017
completion
Jan 27, 2017
last updated
Apr 9, 2024
detailed description
All patients will receive Topicort® twcie daily (BID) for 4 weeks. After week 4 patients will receive Topicort® twice weekly (on consecutive days) for 12 weeks, Patients will treat other body areas affected by plaque psoriasis with Topicort® during the study period (excludes face, groin, axilla)
official title
An Open-Label, Study Evaluating Topicort® Topical Spray 0.25% (Desoximetasone) in Patients With Scalp Psoriasis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol